Radiopharm Theranostics RADX
NASDAQ RADX
$1.48 -0.14 (-8.64%)
At close: Oct 1, 2026 · 4:00 PM EDT

Radiopharm Theranostics (RADX) Long-Term Investments (2025 - 2026)

Updated

Radiopharm Theranostics' Long-Term Investments was $335,001 in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 66.8% from $200,885 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Long-Term Investments (2025 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Long-Term Investments at Radiopharm Theranostics came in at $320,741, up 59.7% from FY2025.

  • In earlier fiscal years, Long-Term Investments was $200,885 in FY2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Radiopharm Theranostics 5.74 Bn 5.70 Bn 186,835.86 335,000.61
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 335,000.61
Jun 30, 2025 200,885.32
API Access

Radiopharm Theranostics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=RADX&period=max&api_key=YOUR_API_KEY